Human Latent TGF beta-1 Flow Cytomtery Assay |
HX87434 |
Antigenix America |
96 tests |
EUR 270 |
Human IgG antibody Laboratories manufactures the adding tgf beta to jurkat assay reagents distributed by Genprice. The Adding Tgf Beta To Jurkat Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tgf assay. Other Adding products are available in stock. Specificity: Adding Category: Tgf Group: Beta To
TGF beta 1 antibody |
Fitzgerald |
100 ul |
EUR 354 |
Description: Mouse monoclonal TGF beta 1 antibody |
TGF beta 1 antibody |
Fitzgerald |
500 ug |
EUR 327.6 |
Description: Mouse monoclonal TGF beta 1 antibody |
TGF beta 1 antibody |
Fitzgerald |
100 ug |
EUR 162 |
Description: Affinity purified Goat polyclonal TGF beta 1 antibody |
TGF beta 2 antibody |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal TGF beta 2 antibody |
TGF beta 3 antibody |
Fitzgerald |
100 ug |
EUR 807.6 |
Description: Rabbit polyclonal TGF beta 3 antibody |
Beta To information
STAT3 Reporter Jurkat Cell Line |
78497 |
BPS Bioscience |
2 vials |
EUR 1900 |
Description: The STAT3 Reporter Jurkat cell line is designed for monitoring the STAT3 signal transduction pathway. It contains a firefly luciferase gene driven by STAT3 response elements located upstream of the minimal TATA promoter. After activation by cytokines or growth factors, endogenous STAT3 binds to the DNA response elements, inducing transcription of the luciferase reporter gene. |
Cas9 Expressing Jurkat Cell Line |
T3261 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 795 |
Jurkat, Clone E6-1 Cell Line |
CL-0129 |
Elabscience Biotech |
1×10⁶ cells/vial |
EUR 420 |
|
Description: Homo sapiens, Human |
Cas9-Expressing Jurkat cell pool |
78070 |
BPS Bioscience |
2 million cells |
EUR 795 |
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene. Cas9-expressing Jurkat cells can be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines. |
Firefly Luciferase Jurkat Cell Line |
78373 |
BPS Bioscience |
2 vials |
EUR 1900 |
Description: Recombinant Jurkat cells constitutively expressing the firefly (Photinus pyralis) luciferase reporter gene under the control of a CMV promoter. |
Human Jurkat Cell Lysate Lyophilized |
IHUJURKATTLLY200UG |
Innovative research |
each |
EUR 89 |
|
Description: Human Jurkat Cell Lysate Lyophilized |
cDNA - Human Tumor Cell Line: Jurkat |
C1255815 |
Biochain |
40 reactions |
EUR 385 |
TCR/B2M Knockout Jurkat Cell Line |
78552 |
BPS Bioscience |
2 vials |
EUR 8645 |
Description: This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from Jurkat cells to generate the TCR Knockout Jurkat cell Line (BPS Bioscience #78539). These TCR knockout cells were then used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing. |
NFAT Reporter (Luc) - Jurkat Cell Line |
60621 |
BPS Bioscience |
2 vials |
EUR 2295 |
Description: The NFAT Reporter - Jurkat Cell Line contains a firefly luciferase gene under the control of the_x000D_NFAT response element stably integrated into Jurkat cells. This cell line has been validated for_x000D_response to thapsigargin, ionomycin, and phorbol 12-myristate 13-acetate (PMA). It is useful as_x000D_a control cell line for other NFAT reporter cell lines expressing various immune checkpoint_x000D_receptors. |
Cas9 Expressing Jurkat E6.1 Cell Line |
T3273 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 795 |
TIGIT / NFAT Reporter - Jurkat Cell Line |
60538 |
BPS Bioscience |
2 vials |
EUR 10855 |
Description: Recombinant Jurkat cell line constitutively expressing a full length human TIGIT (T_x000D_cell Immunoreceptor with Immunoglobulin and ITIM domain; VSTM3), and a firefly luciferase_x000D_gene under the control of nuclear factor of activator T cells (NFAT) response element. Both_x000D_TIGIT and NFAT constructs have been stably integrated into Jurkat cells. TIGIT expression has_x000D_been confirmed by Western Blot, and TIGIT-specific NFAT response has been validated using a_x000D_TIGIT ligand, CD155 (PVR). |
Jurkat cell Lysate (Camptothecin-treated) |
2402-100 |
Biovision |
each |
EUR 222 |
FCGR2A (CD32A) Knockout Jurkat Cell Line |
78549 |
BPS Bioscience |
2 vials |
EUR 6500 |
Description: The FCGR2A Knockout Jurkat cell line was generated by CRISPR/Cas9 genome editing to remove FCGR2A (CD32A), the gene encoding protein FcγRIIa (Fragment crystallizable gamma receptor II a, also known as FcGRIIa, Fc-gamma-RIIa, and CD32A). |
GFP Stably Expressing Jurkat Cell Line |
T3920 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 1450 |
RFP Stably Expressing Jurkat Cell Line |
T3941 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 1450 |
NonO Stable Knockdown Jurkat Cell Line |
T6124 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |